PRESS RELEASE published on 05/01/2024 at 18:18, 6 months 22 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 200,000 of its own ordinary shares on the London Stock Exchange as part of a buy-back program London Stock Exchange Buy-back Program Share Purchase Cancellation Funding Circle Plc
BRIEF published on 04/30/2024 at 18:25, 6 months 23 days ago Funding Circle Plc Completes Share Buyback Transaction Share Buyback Stock Market Share Cancellation Funding Circle Investor Information
PRESS RELEASE published on 04/30/2024 at 18:20, 6 months 23 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 250,000 of its ordinary shares from Numis Securities Limited at a volume-weighted average price of 67.0727p per share on the London Stock Exchange London Stock Exchange Share Repurchase Numis Securities Limited Cancellation Funding Circle Plc
BRIEF published on 04/30/2024 at 16:24, 6 months 23 days ago Funding Circle Plc Announces Total Voting Rights as of April 30, 2024 Share Capital Disclosure And Transparency Total Voting Rights Financial Conduct Authority Funding Circle
PRESS RELEASE published on 04/30/2024 at 16:19, 6 months 23 days ago Funding Circle Plc: TVR-Total Voting Rights Funding Circle Plc announces Total Voting Rights for shareholders. Company's issued share capital details provided for transparency and shareholder notifications Share Capital Disclosure And Transparency Rules Total Voting Rights Funding Circle Plc SME Lending Platform
BRIEF published on 04/29/2024 at 18:08, 6 months 24 days ago Funding Circle Plc Completes Share Buyback Transaction Share Buyback Investor Relations Stock Market Financial Regulation Funding Circle
PRESS RELEASE published on 04/29/2024 at 18:03, 6 months 24 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces the purchase and cancellation of 33,768 ordinary shares, part of a buy-back program. Share capital to consist of 355,910,830 shares post cancellation Share Buy-back London Stock Exchange Ordinary Shares Cancellation Funding Circle Plc
BRIEF published on 04/25/2024 at 18:04, 6 months 28 days ago Funding Circle Plc Announces Completion of Share Buyback Share Buyback Stock Exchange Financial Regulation Numis Securities Funding Circle
PRESS RELEASE published on 04/25/2024 at 17:59, 6 months 28 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces transaction in own shares, purchasing and cancelling 120,000 ordinary shares on the London Stock Exchange London Stock Exchange Own Shares Cancellation Funding Circle Plc Transaction
BRIEF published on 04/23/2024 at 18:11, 7 months ago Funding Circle Plc Announces Share Buy-Back Transaction Share Buy-back London Stock Exchange Regulatory Compliance Stock Market Funding Circle
Published on 11/22/2024 at 23:55, 1 day ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 1 hour ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 1 day 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 1 day 6 hours ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 7 hours ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/21/2024 at 06:58, 2 days 16 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 4 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 6 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 6 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
